Japan’s First Committee On Drugs Recommends Novel Insomnia Drug
This article was originally published in PharmAsia News
Executive Summary
A Japanese committee recommended for approval two products on August 1 including the novel insomnia drug Belsomra (suvorexant), an orexin receptor antagonist from MSD.